摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-(6-chloro-pyrimidin-4-ylamino)-1-(4-fluoro-phenyl)-ethanol | 1184850-40-5

中文名称
——
中文别名
——
英文名称
(R)-2-(6-chloro-pyrimidin-4-ylamino)-1-(4-fluoro-phenyl)-ethanol
英文别名
(1R)-2-[(6-chloropyrimidin-4-yl)amino]-1-(4-fluorophenyl)ethanol
(R)-2-(6-chloro-pyrimidin-4-ylamino)-1-(4-fluoro-phenyl)-ethanol化学式
CAS
1184850-40-5
化学式
C12H11ClFN3O
mdl
——
分子量
267.69
InChiKey
PTSNZRNAKUNVDJ-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    476.4±45.0 °C(Predicted)
  • 密度:
    1.431±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    58
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    2-氯代-4'-氟苯乙酮 在 5%-palladium/activated carbon sodium azide 、 硼烷四氢呋喃络合物氢气碳酸氢钠(R)-2-甲基-CBS-恶唑硼烷 作用下, 以 四氢呋喃1,4-二氧六环乙醇N,N-二甲基甲酰胺 为溶剂, 20.0~100.0 ℃ 、344.75 kPa 条件下, 反应 130.0h, 生成 (R)-2-(6-chloro-pyrimidin-4-ylamino)-1-(4-fluoro-phenyl)-ethanol
    参考文献:
    名称:
    [EN] ARYL-HYDROXYETHYLAMINO-PYRIMIDINES AND TRIAZINES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE
    [FR] ARYL-HYDROXYÉTHYLAMINO-PYRIMIDINES ET TRIAZINES EN TANT QUE MODULATEURS D'AMIDE D'ACIDE GRAS HYDROLASE
    摘要:
    描述了某些芳基-羟乙基氨基嘧啶和三嗪化合物,这些化合物可用作FAAH抑制剂。这些化合物可用于制备药物组合物和治疗由脂肪酸酰胺水解酶(FAAH)活性介导的疾病状态、紊乱和症状,如焦虑、疼痛、炎症、睡眠障碍、进食障碍、能量代谢障碍和运动障碍(例如多发性硬化)。还公开了合成这些化合物的方法。
    公开号:
    WO2009105220A1
点击查看最新优质反应信息

文献信息

  • Aryl - Hydroxyethylamino - Pyrimidines and Triazines as Modulators of Fatty Acid amide Hydrolase
    申请人:Apodaca Richard
    公开号:US20090264429A1
    公开(公告)日:2009-10-22
    Certain aryl-hydroxyethylamino-pyrimidine and triazine compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.
    描述了某些芳基-羟乙基氨基嘧啶和三嗪化合物,这些化合物可用作FAAH抑制剂。这些化合物可以用于制备药物组合物和治疗由脂肪酸酰胺水解酶(FAAH)活性介导的疾病状态、障碍和病况的方法,例如焦虑、疼痛、炎症、睡眠障碍、进食障碍、能量代谢障碍和运动障碍(例如多发性硬化症)。还公开了合成这些化合物的方法。
  • Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
    申请人:Apodaca Richard
    公开号:US08598202B2
    公开(公告)日:2013-12-03
    Certain aryl-hydroxyethylamino-pyrimidine and triazine compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.
    本文介绍了某些芳基-羟乙基氨基嘧啶和三嗪化合物,它们可用作FAAH(脂肪酸酰胺水解酶)抑制剂。这些化合物可用于制备药物组合物和治疗由FAAH活性介导的疾病状态、疾病和情况,例如焦虑、疼痛、炎症、睡眠障碍、进食障碍、能量代谢障碍和运动障碍(如多发性硬化症)。本文还揭示了合成这些化合物的方法。
  • ARYL-HYDROXYETHYLAMINO-PYRIMIDINES AND TRIAZINES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE
    申请人:Janssen Pharmaceutica, N.V.
    公开号:EP2254415B1
    公开(公告)日:2013-01-23
  • US8598202B2
    申请人:——
    公开号:US8598202B2
    公开(公告)日:2013-12-03
  • [EN] ARYL-HYDROXYETHYLAMINO-PYRIMIDINES AND TRIAZINES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE<br/>[FR] ARYL-HYDROXYÉTHYLAMINO-PYRIMIDINES ET TRIAZINES EN TANT QUE MODULATEURS D'AMIDE D'ACIDE GRAS HYDROLASE
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2009105220A1
    公开(公告)日:2009-08-27
    Certain aryl-hydroxyethylamino-pyrimidine and triazine compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.
    描述了某些芳基-羟乙基氨基嘧啶和三嗪化合物,这些化合物可用作FAAH抑制剂。这些化合物可用于制备药物组合物和治疗由脂肪酸酰胺水解酶(FAAH)活性介导的疾病状态、紊乱和症状,如焦虑、疼痛、炎症、睡眠障碍、进食障碍、能量代谢障碍和运动障碍(例如多发性硬化)。还公开了合成这些化合物的方法。
查看更多